Statement by FDA Commissioner Scott Gottlieb, M.D., and Biologics Center Director Peter Marks, M.D., Ph.D. on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unap…

FDA statement on stem cell enforcement actions and agency activities to facilitate legitimate product development…

Sourced through Scoop.it from: www.fda.gov